Expression and correlation of Lewis y antigen and TGF-β1 in ovarian epithelial carcinoma

Oncology Reports

Volumn 27, Issue 4, 2012, Pages 1065-1071

  Wang, Sheng Tan ^a,b   Liu, Juan Juan ^a   Wang, Chang Zhi ^c   Lin, Bei ^a   Hao, Ying Ying ^a   Wang, Yi Fei ^c   Gao, Song ^a   Qi, Yue ^a   Zhang, Shu Lan ^a   Iwamori, Masao ^d  

^a CHINA MEDICAL UNIVERSITY   (China)

^b HAINAN PROVINCIAL PEOPLE S HOSPITAL   (China)

^c DALIAN MEDICAL UNIVERSITY   (China)

^d KINKI UNIVERSITY   (Japan)

Author keywords

Immunofluorescence double labeling method; Immunohistochemistry; Lewis y; Ovarian epithelial carcinoma; Transforming growth factor 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; AGED; ANGIOGENESIS; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; BLOOD GROUP LEWIS SYSTEM; CANCER GRADING; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CELL PROLIFERATION; CHI-SQUARE DISTRIBUTION; CHINA; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; LEWIS BLOOD-GROUP SYSTEM; LINEAR MODELS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; TRANSFORMING GROWTH FACTOR BETA1; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; YOUNG ADULT;

EID: 84863061554     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1575     Document Type: Article

References (24)

1. Goupille C, Hallouin F, Meflah K and Le Pendu J: Increase of rat colon carcinoma cells tumorigenicity by alpha(1-2) fucosyltransferase gene transfection. Glycobiology 7: 221-229, 1997. (Pubitemid 27168777)
2. Hellström I, Garrigues HJ, Garrigues U and Hellström KE: Highly tumor-reactive, internalizing, mouse monoclonal antibodies to Le(y)-related cell surface antigens. Cancer Res 50: 2183-2190, 1990.
3. Markowitz S: TGF-beta receptors and DNA repair genes, coupled targets in a pathway of human colon carcinogenesis. Biochim Biophs Acta 1470: M13-M20, 2000.
4. Shah AH and Lee C: TGF-beta-based immunotherapy for cancer: breaching the tumor firewall. Prostate 45: 167-172, 2000.
5. Ahmed AA, Mills AD, Ibrahim AE, et al: The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel. Cancer Cell 12: 514-527, 2007.
6. Iwamori M, Tanaka K, Kubushiro K, et al: Alterations in the glyolipid composition and cellular properties of ovarian carcinoma-derived RMG-1 cells on transfection of the α1,2-fucosyltransferase gene. Cancer Sci 96: 26-30, 2005. (Pubitemid 40310021)
7. Zhao Y, Lin B, Hao YY, Yan LM, Liu JJ, Zhu LC and Zhang SL: The effects of Lewis(y) antigen content on drug resistance to carboplatin in ovarian cancer line RMG-I. Prog Biochem Biophys 35: 1175-1182, 2008.
8. Hao YY, Lin B, Zhao Y, et al: alpha1,2-fucosyltransferase gene transfection influences on biological behavior of ovarian carcinoma-derived RMG-1 cells. Fen Zi Xi Bao Sheng Wu Xue Bao 41: 435-442, 2008 (In Chinese).
9. Zhu K, Amin MA, Zha Y, Harlow LA and Koch AE: Mechanism by which H-2g, a glucose analog of blood group H antigen, mediates angiogenesis. Blood 105: 2343-2349, 2005. (Pubitemid 40387029)
10. Yasui T, Uemura H, Irahara M and Aono T: Effects of transforming growth factor-beta on the production of parathyroid hormone-related peptide in a human ovarian cancer cell line in vitro. J Obstet Gynaecol Res 23: 231-238, 1997. (Pubitemid 27292476)
11. Derynck R and Zhang YE: Smad-dependent and Smad-independent pathways in TGF-beta family signaling. Nature 425: 577-584, 2003.
12. de Caestecker MP, Piek E and Roberts AB: Role of transforming growth factor-beta signaling in cancer. J Natl Cancer Inst 92: 1388-1402, 2000.
13. Hempel N, How T, Dong M, Murphy SK, Fields TA and Blobe GC: Loss of betaglycan expression in ovarian cancer: role in motility and invasion. Cancer Res 67: 5231-5238, 2007. (Pubitemid 46997261)
14. Rodriguez GC, Haisley C, Hurteau J, Moser TL, Whitaker R, Bast RC Jr and Stack MS: Regulation of invasion of epithelial ovarian cancer by transforming growth factor-beta. Gynecol Oncol 80: 245-253, 2001. (Pubitemid 32158466)
15. Hirashima Y, Kobayashi H, Suzuki M, Tanaka Y, Kanayama N and Terao T: Transforming growth factor-beta1 produced by ovarian cancer cell line HRA stimulates attachment and invasion through an up-regulation of plasminogen activator inhibitor type-1 in human peritoneal mesothelial cells. J Biol Chem 278: 26793-26802, 2003. (Pubitemid 36876828)
16. Bristow RE, Baldwin RL, Yamada SD, Korc M and Karlan BY: Altered expression of transforming growth factor-beta ligands and receptors in primary and recurrent ovarian carcinoma. Cancer 85: 658-668, 1999. (Pubitemid 29075287)
17. Hakomori S: Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res 56: 5309-5318, 1996.
18. Breier G, Blum S, Peli J, Groot M, Wild C, Risau W and Reichmann E: Transforming growth factor-beta and Ras regulate the VEGF/VEGF-receptor system during tumor angiogenesis. Int J Cancer 97: 142-148, 2002. (Pubitemid 34019947)
19. Donovan D, Harmey JH, Toomey D, Osborne DH, Redmond HP and Bouchier-Hayes DJ: TGF beta-1 regulation of VEGF production by breast cancer cells. Ann Surg Oncol 4: 621-627, 1997.
20. Li Y, Lin B, Hao YY, et al: Influence of alpha1,2-fucosyltransferase gene transfection on vascular endothelial growth factor in ovarian carcinoma-derived RMG-I cell xenografts in nude mice. J China Med Univ 3: 284-289, 2008 (In Chinese).
21. Wang PL, Lin B, Liu Q, Li Y, Li FF, Hao YY and Zhang SL: Lewis y antigen promotes the expression of vascular endothelial growth factor receptor in ovarian carcinoma-derived RMG-I cells. J Modern Oncol 17: 1831-1835, 2009.
22. Liu JJ, Lin B, Hao YY, et al: Lewis(y) antigen stimulates the growth of ovarian cancer cells via regulation of the epidermal growth factor receptor pathway. Oncol Rep 23: 833-841, 2010.
23. Scott S, Kimura T, Ichinohasama R, et al: Microsatellite mutations of transforming growth factor-beta receptor type II and caspase-5 occur in human precursor T-cell lymphoblastic lymphomas/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter methylation. Leuk Res 27: 23-34, 2003. (Pubitemid 35449713)
24. Langermans JA, Nibbering PH, Van Vuren-Van Der Hulst ME and Van Furth R: Transforming growth factor-beta suppresses interferon-gamma-induced toxoplasmastatic activity in murine macrophages by inhibition of tumour necrosis factor-alpha production. Parasite Immunol 23: 169-175, 2001. (Pubitemid 32391389)